Related Experiment Video
Updated: Jul 5, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Epileptogenesis causes an N-methyl-d-aspartate receptor/Ca2+-dependent decrease in Ca2+/calmodulin-dependent protein
Robert E Blair1, Sompong Sombati, Severn B Churn
1Department of Neurology, Virginia Commonwealth University, School of Medicine, Richmond, Virginia 23298-0599, United States. rblair@vcu.edu
Abstract:
Alterations in the function of Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) have been observed in both in vivo and in vitro models of epileptogenesis; however the molecular mechanism mediating the effects of epileptogenesis on CaM kinase II has not been elucidated. This study was initiated to evaluate the molecular pathways involved in causing the long-lasting decrease in CaM kinase II activity in the hippocampal neuronal culture model of low Mg2+-induced spontaneous recurrent epileptiform discharges (SREDs). We show here that the decrease in CaM kinase II activity associated with SREDs in hippocampal cultures involves a Ca2+/N-methyl-d-aspartate (NMDA) receptor-dependent mechanism. Low Mg2+-induced SREDs result in a significant decrease in Ca2+/calmodulin-dependent substrate phosphorylation of the synthetic peptide autocamtide-2. Reduction of extracellular Ca2+ levels (0.2 mM in treatment solution) or the addition of dl-2-amino-5-phosphonovaleric acid (APV) 25 microM blocked the low Mg2+-induced decrease in CaM kinase II-dependent substrate phosphorylation. Antagonists of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)/kainic acid receptor or L-type voltage sensitive Ca2+ channel had no effect on the low Mg2+-induced decrease in CaM kinase II-dependent substrate phosphorylation. The results of this study demonstrate that the decrease in CaM kinase II activity associated with this model of epileptogenesis involves a selective Ca2+/NMDA receptor-dependent mechanism and may contribute to the production and maintenance of SREDs in this model.
Insights
This study reveals that Ca2+/N-methyl-d-aspartate (NMDA) receptor activation mediates the decrease in CaM kinase II activity during low magnesium-induced epilepsy models, potentially contributing to seizure maintenance.
Area of Science:
- Neuroscience
- Molecular Biology
- Epilepsy Research
Background:
- Alterations in Ca2+/calmodulin-dependent protein kinase II (CaM kinase II) function are implicated in epileptogenesis.
- The precise molecular mechanisms linking epilepsy to CaM kinase II dysfunction remain unclear.
Purpose of the Study:
- To investigate the molecular pathways responsible for reduced CaM kinase II activity in a hippocampal culture model of low magnesium-induced spontaneous recurrent epileptiform discharges (SREDs).
Main Methods:
- Utilized a low Mg2+ hippocampal neuronal culture model to induce SREDs.
- Assessed CaM kinase II activity via substrate phosphorylation (autocamtide-2).
- Examined the role of Ca2+ levels, NMDA receptors, AMPA/kainate receptors, and L-type Ca2+ channels using specific antagonists and reduced extracellular Ca2+.
Main Results:
- Low Mg2+-induced SREDs significantly decreased CaM kinase II-dependent substrate phosphorylation.
- Reducing extracellular Ca2+ or adding APV (NMDA receptor antagonist) blocked this decrease.
- AMPA/kainate receptor antagonists and L-type Ca2+ channel blockers did not affect the CaM kinase II activity reduction.
Conclusions:
- The reduction in CaM kinase II activity during low Mg2+-induced SREDs is mediated by a selective Ca2+/NMDA receptor-dependent pathway.
- This mechanism may play a role in the generation and persistence of SREDs in this epilepsy model.
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Integration of Synaptic Events

